Target Name: STK19
NCBI ID: G8859
Review Report on STK19 Target / Biomarker Content of Review Report on STK19 Target / Biomarker
STK19
Other Name(s): G11 | HLA-RP1 | MHC class III HLA-RP1 | Serine/threonine kinase 19 | RP1 | G11-Z | Nuclear serine/threonine protein kinase | Serine/threonine kinase 19, transcript variant 2 | nuclear serine/threonine protein kinase | Protein RP1 | Protein G11 | serine/threonine kinase 19 | STK19_HUMAN | STK19 variant 2 | Serine/threonine-protein kinase 19 | D6S60E | Serine/threonine-protein kinase 19 (isoform 2) | D6S60

Understanding The Potential Role of STK19 as A Drug Target

STK19 (G11) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and muscle. It is a member of the STK family of proteins, which are known for their role in cell signaling. STK19 has been identified as a potential drug target (or biomarker) due to its involvement in a variety of cellular processes, including cell proliferation, differentiation, and survival.

One of the key functions of STK19 is its role in cell signaling. STK19 is a member of the STK family of proteins, which are known for their ability to phosphorylase and inositolate intracellular signaling pathways (A, B). These signaling pathways are important for the regulation of cellular processes such as cell growth, differentiation, and survival. STK19 plays a key role in the regulation of cell proliferation by participating in the S/T kinase signaling pathway (C).

In addition to its role in cell signaling, STK19 is also involved in the regulation of cellular processes related to protein synthesis and degradation. It has been shown to play a role in the regulation of protein synthesis by interacting with the protein encoded by the gene SNAPK (D). This interaction between STK19 and SNAPK allows for the regulation of protein synthesis and degradation, which is important for maintaining cellular homeostasis (E).

STK19 has also been shown to play a role in the regulation of cellular processes related to cell adhesion and migration. It has been shown to interact with the protein encoded by the gene E-cadherin (F), which is a protein that plays a role in cell adhesion and migration (G). This interaction between STK19 and E-cadherin allows for the regulation of cell adhesion and migration, which is important for the proper functioning of tissues and organs (H).

In conclusion, STK19 is a protein that is involved in a variety of cellular processes, including cell signaling, protein synthesis and degradation, and cell adhesion and migration. Its involvement in these processes makes it a potential drug target (or biomarker) with potential for the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of STK19 in cellular processes and its potential as a drug target.

Protein Name: Serine/threonine Kinase 19

Functions: Serine/threonine-protein kinase that acts as a key regulator of NRAS signaling by mediating phosphorylation of NRAS at 'Ser-89', thereby enhancing NRAS-binding to its downstream effectors

The "STK19 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about STK19 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

STK24 | STK25 | STK26 | STK3 | STK31 | STK32A | STK32A-AS1 | STK32B | STK32C | STK33 | STK35 | STK36 | STK38 | STK38L | STK39 | STK4 | STK4-DT | STK40 | STKLD1 | STMN1 | STMN2 | STMN3 | STMN4 | STMND1 | STMP1 | STN1 | STOM | STOML1 | STOML2 | STOML3 | STON1 | STON1-GTF2A1L | STON2 | Store-operating calcium channel channels | STOX1 | STOX2 | STPG1 | STPG2 | STPG3 | STPG3-AS1 | STPG4 | STRA6 | STRA6LP | STRA8 | STRADA | STRADB | STRAP | STRBP | STRC | STRCP1 | STRIP1 | STRIP2 | STRIT1 | STRN | STRN3 | STRN4 | STS | STT3A | STT3A-AS1 | STT3B | STUB1 | STUM | STX10 | STX11 | STX12 | STX16 | STX16-NPEPL1 | STX17 | STX17-DT | STX18 | STX18-AS1 | STX18-IT1 | STX19 | STX1A | STX1B | STX2 | STX3 | STX4 | STX5 | STX5-DT | STX6 | STX7 | STX8 | STXBP1 | STXBP2 | STXBP3 | STXBP4 | STXBP5 | STXBP5-AS1 | STXBP5L | STXBP6 | STYK1 | STYX | STYXL1 | STYXL2 | SUB1 | SUB1P1 | Succinate Dehydrogenase Complex | Succinate-CoA ligase (ADP-forming) | SUCLA2